Study of new metabolites for heart valve disease
Part of Heart & circulation clinical trials.
This study looks at certain byproducts in your body (metabolites) that may be linked to heart valve disease. The goal is to understand how they work, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of heart valve disease, such as aortic stenosis or mitral regurgitation.
- You must be able to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
This trial uses advanced CT scans to study people with moderate or severe heart valve disease. It aims to better understand valve problems and may help guide future treatments.
This study looks at people who have two or more heart valve problems that are moderate to severe. It aims to learn more about this condition and how to best manage it.
This study is following people with heart valve disease (leaky or narrowed valves) to understand how the disease changes over time and what problems it may cause. It does not test a new treatment, but helps doctors learn more about valve disease progression.
This trial uses a special MRI and blood tests to see how heart muscle is affected after aortic or mitral valve surgery. It may help doctors better understand and monitor heart recovery.
This study looks for biological markers in the blood that might help predict heart-related events in people with a narrowed aortic heart valve. It aims to improve care for those with this condition, whether or not they have a procedure called TAVI to replace the valve.
Hear when a new Valvular Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.